financetom
Business
financetom
/
Business
/
RXO To Buy Coyote Logistics From UPS In Billion-Dollar Deal - What's On The Move?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RXO To Buy Coyote Logistics From UPS In Billion-Dollar Deal - What's On The Move?
Jun 24, 2024 5:00 AM

RXO, Inc. ( RXO ) shares are trading higher after the company inked a definitive agreement to acquire Coyote Logistics from United Parcel Service, Inc. ( UPS ) for $1.025 billion in cash.

As per the terms, the transaction disclosed on Sunday will be financed through a combination of equity and debt, including a $300 million equity investment from MFN Partners and a $250 million equity investment from Orbis Investments, both significant shareholders of RXO.

RXO will maintain its role in fulfilling UPS’s brokered transportation requirements under an existing contract valid until January 2030.

This acquisition is expected to bolster RXO’s market standing, broaden its customer base, and expand its network of carriers.

RXO’s Board of Directors has unanimously approved the transaction, which is expected to be finalized by the end of 2024 subject to customary closing conditions and regulatory approvals.

Upon deal closure, RXO is set to become the third-largest provider of brokered transportation services in North America.

The transaction is anticipated to immediately and substantially enhance RXO’s adjusted EPS and adjusted free cash flow.

In 2023, the acquired business generated around $3.2 billion in revenue, with around $470 million in gross margin and about $86 million in adjusted EBITDA.

Outlook: RXO maintains its outlook for the second quarter adjusted EBITDA of $24 million to $30 million.

RXO anticipates achieving annualized cost synergies of at least $25 million from the buyout.

Drew Wilkerson, chief executive officer of RXO said, “RXO will realize significant synergies from the acquisition by quickly integrating Coyote’s business into RXO and leveraging our cutting-edge technology. The addition of Coyote’s customer base will diversify RXO’s vertical mix and will increase the number of customers that do more than $1 million in business with us by approximately 80%.”

UPS Chief Executive Officer Carol B. Tomé commented, “As UPS positions itself to become the premium small package provider and logistics partner in the world, the decision to sell our Coyote Logistics business allows an even greater focus on our core business.”

Upon completion of the transaction, UPS plans to update its financial outlook.

As of March 31, 2024, RXO’s cash and cash equivalents stood at $7 million.

Investors can gain exposure to RXO via Motley Fool Small-Cap Growth ETF .

Price Action: RXO shares are up 13.8% at $23.00 premarket at the last check Monday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Range Capital Acquisition Corp. II Prices Initial Public Offering
Range Capital Acquisition Corp. II Prices Initial Public Offering
Oct 3, 2025
03:49 AM EDT, 10/03/2025 (MT Newswires) -- Range Capital Acquisition Corp. II said late Thursday it has priced its initial public offering of 20 million units at $10 per unit. Each unit, expected to begin Nasdaq trading Friday under the ticker RNGTU, consists of one share and one-half of a redeemable warrant, the blank-check company said. Once the securities begin...
Jazz Pharmaceuticals Says US FDA Approves Zepzelcain Combo for Treatment of Extensive-Stage Small Cell Lung Cancer
Jazz Pharmaceuticals Says US FDA Approves Zepzelcain Combo for Treatment of Extensive-Stage Small Cell Lung Cancer
Oct 3, 2025
03:56 AM EDT, 10/03/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Thursday that the US Food and Drug Administration approved Zepzelcain in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs as a maintenance treatment for adults with extensive-stage small cell lung cancer. The specific indication is patients whose disease has not progressed after first-line induction therapy with other medicines,...
Mesoblast Secures J-Code From Medicare & Medicaid Services for Rare Disease Treatment Ryoncil
Mesoblast Secures J-Code From Medicare & Medicaid Services for Rare Disease Treatment Ryoncil
Oct 3, 2025
04:09 AM EDT, 10/03/2025 (MT Newswires) -- Mesoblast (MESO) said late Thursday that the US Medicare & Medicaid Services has assigned a J-Code to graft-versus-host disease treatment Ryoncil. The permanent J-Code, J3402, facilitates reimbursement and broader patient access for the drug, the drugmaker said. Healthcare providers can start using the code for claims filed on or after Oct. 1, Mesoblast...
Legacy Housing CEO Robert Duncan Bates Resigns; Interim CEO Named
Legacy Housing CEO Robert Duncan Bates Resigns; Interim CEO Named
Oct 3, 2025
03:57 AM EDT, 10/03/2025 (MT Newswires) -- Legacy Housing ( LEGH ) said Thursday that Chief Executive Robert Duncan Bates has resigned, effective Oct. 10, due to personal reasons. Kenneth Shipley, the company's co-founder, took over as CEO on Wednesday on an interim basis, while the firm searches for a successor to Bates. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved